BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3034188)

  • 1. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.
    Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA
    Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.
    Gaio JM; Pollak P; Hommel M; Perret J
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1674-8. PubMed ID: 3437301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders.
    Stahl SM; Thornton JE; Simpson ML; Berger PA; Napoliello MJ
    Biol Psychiatry; 1985 Aug; 20(8):888-93. PubMed ID: 3861199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gamma-vinyl GABA in tardive dyskinesia.
    Korsgaard S; Casey DE; Gerlach J
    Psychiatry Res; 1983 Apr; 8(4):261-9. PubMed ID: 6136054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA agonist treatment improves tardive dyskinesia.
    Tamminga CA; Thaker GK; Ferraro TN; Hare TA
    Lancet; 1983 Jul; 2(8341):97-8. PubMed ID: 6134975
    [No Abstract]   [Full Text] [Related]  

  • 6. Schizophrenia, tardive dyskinesia, and brain GABA.
    Perry TL; Hansen S; Jones K
    Biol Psychiatry; 1989 Jan; 25(2):200-6. PubMed ID: 2564786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA system: clinical research and treatment of tardive dyskinesia.
    Thaker GK; Hare TA; Tamminga CA
    Mod Probl Pharmacopsychiatry; 1983; 21():155-67. PubMed ID: 6419061
    [No Abstract]   [Full Text] [Related]  

  • 8. gamma-Acetylenic GABA in tardive dyskinesia.
    Casey DE; Gerlach J; Magelund G; Christensen TR
    Arch Gen Psychiatry; 1980 Dec; 37(12):1376-9. PubMed ID: 6108751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias.
    Andersson U; Häggström JE
    Psychopharmacology (Berl); 1988; 94(3):298-301. PubMed ID: 2895937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA agonist-induced changes in motor, oculomotor, and attention measures correlate in schizophrenics with tardive dyskinesia.
    Cassady SL; Thaker GK; Moran M; Birt A; Tamminga CA
    Biol Psychiatry; 1992 Aug; 32(4):302-11. PubMed ID: 1358231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.
    Korsgaard S; Casey DE; Gerlach J; Hetmar O; Kaldan B; Mikkelsen LB
    Arch Gen Psychiatry; 1982 Sep; 39(9):1017-21. PubMed ID: 6126170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of total gamma-aminobutyric acid (GABA), free GABA and homocarnosine in cerebrospinal fluid of epileptic patients before and during gamma-vinyl-GABA (vigabatrin) treatment.
    Pitkänen A; Matilainen R; Ruutiainen T; Riekkinen P
    J Neurol Sci; 1988 Dec; 88(1-3):83-93. PubMed ID: 3225631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia.
    Morselli PL; Fournier V; Bossi L; Musch B
    Psychopharmacology Suppl; 1985; 2():128-36. PubMed ID: 2860656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental studies and controlled clinical testing of valproate and vigabatrin.
    Gram L
    Acta Neurol Scand; 1988 Oct; 78(4):241-70. PubMed ID: 3146860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ; Deeks JJ
    Cochrane Database Syst Rev; 2001; (2):CD000203. PubMed ID: 11405955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
    Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA
    Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-vinyl GABA.
    Hammond EJ; Wilder BJ
    Gen Pharmacol; 1985; 16(5):441-7. PubMed ID: 2932363
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement in tardive dyskinesia after muscimol therapy.
    Tamminga CA; Crayton JW; Chase TN
    Arch Gen Psychiatry; 1979 May; 36(5):595-8. PubMed ID: 35117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid GABA and seizure control with vigabatrin.
    Riekkinen PJ; Ylinen A; Halonen T; Sivenius J; Pitkanen A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):87S-94S. PubMed ID: 2757914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gamma-vinyl-GABA on the human electroencephalogram.
    Hammond EJ; Wilder BJ
    Neuropharmacology; 1985 Oct; 24(10):975-84. PubMed ID: 2999635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.